Mucosal Gene Expression Signatures That Predict Response of Ulcerative Colitis to Infliximab

Gastroenterology

Volumn 140, Issue 2, 2011, Pages 729-731

  Watson, Alastair J M ^a   Tremelling, Mark ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; HYPOCALCIN; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 11 RECEPTOR ALPHA; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN; PROSTAGLANDIN H2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

BIOPSY; DRUG RESPONSE; GENE EXPRESSION; GENE PROBE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN; NOTE; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SIGMOIDOSCOPY; THERAPY EFFECT; ULCERATIVE COLITIS;

EID: 84855656927     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.12.007     Document Type: Note

References (0)